Increased risk of serotonin syndrome and potentiated sympathomimetic effects.
Should not be used concurrently with MAOIs or within 14 days of stopping MAOIs.
Source: DDInter
TCA · Antidepressant
Also known as Clomipramine hydrochloride
Clomipramine hydrochloride, a tricyclic antidepressant, blocks the re-uptake of both serotonin and noradrenaline. It is more selective for serotonergic transmission.
Manufacturer advises avoid.
Increased risk of serotonin syndrome and potentiated sympathomimetic effects.
Should not be used concurrently with MAOIs or within 14 days of stopping MAOIs.
Source: DDInter
Exaggerated hypertensive response
Use local anaesthetic without adrenaline in patients on TCAs
Source: KDT 7e · p950
Potentiation of adrenaline's effects.
Vasoconstrictor (adrenaline) containing LA should be avoided in patients receiving tricyclic antidepressants.
Source: KDT 7e · p365
Increased risk of cardiac conduction defects.
Source: KDT 7e · p816-835
Increased cardiotoxicity (e.g., QT prolongation).
Source: Harrison 22e · p1740
Increased risk of TCA side effects, including cardiac arrhythmias (especially QT prolongation and Torsades de Pointes), and serotonin syndrome.
Avoid concomitant use. If unavoidable, use with extreme caution, starting with a lower dose of clomipramine and monitoring ECG closely for QT prolongation. Consider therapeutic drug monitoring (TDM) for clomipramine.
Source: DDInter
Drug interaction classified as: synergy.
Source: DDInter
Drug interaction classified as: synergy
Source: DDInter
Drug interaction classified as: synergy
Source: DDInter
Drug interaction classified as: synergy
Source: DDInter
Drug interaction classified as: synergy
Source: DDInter
Drug interaction classified as: synergy
Source: DDInter
Continue into a citation-backed clinical answer with the drug context already attached.
Sources: Goodman & Gilman 14e, Harrison 22e, BNF·Verified: 2026-05-13 · House clinical team